Asia-Pacific Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: July 09, 2025 Report Code: GDME20425CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “Asia-Pacific Metabolic Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Diabetes Assays and Cholesterol Tests

The Asia-Pacific Metabolic Disorders Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Metabolic Disorders Market.
• Global corporate-level profiles of key companies operating within the Asia-Pacific Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Metabolic Disorders is segmented as follows –

• Diabetes Assays

• Cholesterol Tests

Reasons to Buy

The Asia-Pacific Metabolic Disorders Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories
Alfa Wassermann Inc
ALPCO Diagnostics
Beckman Coulter Inc
Bio-Rad Laboratories Inc
Danaher Corp
DiaSorin SpA
EKF-diagnostic GmbH

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Metabolic Disorders Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Metabolic Disorders Market, Asia-Pacific 10

3.1 Metabolic Disorders Market, Asia-Pacific, Revenue ($m), 2018-2033 10

3.2 Metabolic Disorders Market, Asia-Pacific, Revenue ($m), 2018-2033 12

3.3 Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 14

3.4 Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 15

3.5 Metabolic Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2024 17

4 Metabolic Disorders Market, Japan 19

4.1 Metabolic Disorders Market, Japan, Revenue ($m), 2018-2033 19

4.1.1 Cholesterol Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 21

4.1.2 Diabetes Assays Market, Japan, Revenue ($m), by Segment, 2018-2033 23

4.2 Metabolic Disorders Market, Japan, Volume (Units), 2018-2033 25

4.2.1 Cholesterol Tests Market, Japan, Volume (Units), by Segment, 2018-2033 27

4.2.2 Diabetes Assays Market, Japan, Volume (Units), by Segment, 2018-2033 30

4.3 Metabolic Disorders Market, Japan, Average Price ($), 2018-2033 32

4.4 Metabolic Disorders Market, Japan, Company Share by Revenue ($m), 2024 33

5 Metabolic Disorders Market, China 35

5.1 Metabolic Disorders Market, China, Revenue ($m), 2018-2033 35

5.1.1 Cholesterol Tests Market, China, Revenue ($m), by Segment, 2018-2033 37

5.1.2 Diabetes Assays Market, China, Revenue ($m), by Segment, 2018-2033 39

5.2 Metabolic Disorders Market, China, Volume (Units), 2018-2033 41

5.2.1 Cholesterol Tests Market, China, Volume (Units), by Segment, 2018-2033 43

5.2.2 Diabetes Assays Market, China, Volume (Units), by Segment, 2018-2033 46

5.3 Metabolic Disorders Market, China, Average Price ($), 2018-2033 49

5.4 Metabolic Disorders Market, China, Company Share by Revenue ($m), 2024 50

6 Metabolic Disorders Market, South Korea 52

6.1 Metabolic Disorders Market, South Korea, Revenue ($m), 2018-2033 52

6.1.1 Cholesterol Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 54

6.1.2 Diabetes Assays Market, South Korea, Revenue ($m), by Segment, 2018-2033 56

6.2 Metabolic Disorders Market, South Korea, Volume (Units), 2018-2033 58

6.2.1 Cholesterol Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 60

6.2.2 Diabetes Assays Market, South Korea, Volume (Units), by Segment, 2018-2033 63

6.3 Metabolic Disorders Market, South Korea, Average Price ($), 2018-2033 65

6.4 Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), 2024 66

7 Metabolic Disorders Market, Australia 68

7.1 Metabolic Disorders Market, Australia, Revenue ($m), 2018-2033 68

7.1.1 Cholesterol Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 70

7.1.2 Diabetes Assays Market, Australia, Revenue ($m), by Segment, 2018-2033 72

7.2 Metabolic Disorders Market, Australia, Volume (Units), 2018-2033 74

7.2.1 Cholesterol Tests Market, Australia, Volume (Units), by Segment, 2018-2033 76

7.2.2 Diabetes Assays Market, Australia, Volume (Units), by Segment, 2018-2033 79

7.3 Metabolic Disorders Market, Australia, Average Price ($), 2018-2033 81

7.4 Metabolic Disorders Market, Australia, Company Share by Revenue ($m), 2024 82

8 Metabolic Disorders Market, India 84

8.1 Metabolic Disorders Market, India, Revenue ($m), 2018-2033 84

8.1.1 Cholesterol Tests Market, India, Revenue ($m), by Segment, 2018-2033 86

8.1.2 Diabetes Assays Market, India, Revenue ($m), by Segment, 2018-2033 88

8.2 Metabolic Disorders Market, India, Volume (Units), 2018-2033 90

8.2.1 Cholesterol Tests Market, India, Volume (Units), by Segment, 2018-2033 92

8.2.2 Diabetes Assays Market, India, Volume (Units), by Segment, 2018-2033 95

8.3 Metabolic Disorders Market, India, Average Price ($), 2018-2033 98

8.4 Metabolic Disorders Market, India, Company Share by Revenue ($m), 2024 99

9 Overview of Key Companies in Asia-Pacific Metabolic Disorders Market 101

9.1 Roche Diagnostics International Ltd 101

9.1.1 Company Overview 101

9.2 Siemens Healthineers AG 101

9.2.1 Company Overview 101

9.3 Beckman Coulter Inc 101

9.3.1 Company Overview 101

9.4 Abbott Laboratories 102

9.4.1 Company Overview 102

9.5 Ortho Clinical Diagnostics Holdings Plc 102

9.5.1 Company Overview 102

10 Metabolic Disorders Market Pipeline Products 103

11 Recent Developments 106

11.1 Government and Public Interest 106

11.1.1 Sep 17, 2024: KKH Launches First Expanded Programme to Screen At-Risk Couples for Genetic Conditions in Singapore 106

12 Appendix 108

12.1 Research Methodology 109

12.1.1 Coverage 109

12.1.2 Secondary Research 109

12.1.3 Primary Research 109

12.1.4 Market Modeling and Forecasting 110

12.1.5 Company Share Analysis 111

12.1.6 Benchmarking 112

12.2 GlobalData Consulting 113

12.3 Contact Us 113

12.4 Disclaimer 113

Table

Table 1: Metabolic Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Metabolic Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 13

Table 3: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 14

Table 4: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 16

Table 5: Metabolic Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2024 18

Table 6: Metabolic Disorders Market, Japan, Revenue ($m), USD Constant, 2018-2033 20

Table 7: Cholesterol Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 22

Table 8: Diabetes Assays Market, Japan, Revenue ($m), USD Constant, 2018-2033 24

Table 9: Metabolic Disorders Market, Japan, Volume (Units), 2018-2033 26

Table 10: Cholesterol Tests Market, Japan, Volume (Units), 2018-2033 28

Table 11: Diabetes Assays Market, Japan, Volume (Units), 2018-2033 31

Table 12: Metabolic Disorders Market, Japan, Average Price ($), 2018-2033 32

Table 13: Metabolic Disorders Market, Japan, Company Share by Revenue ($m), 2024 34

Table 14: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2018-2033 36

Table 15: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2018-2033 38

Table 16: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2018-2033 40

Table 17: Metabolic Disorders Market, China, Volume (Units), 2018-2033 42

Table 18: Cholesterol Tests Market, China, Volume (Units), 2018-2033 44

Table 19: Diabetes Assays Market, China, Volume (Units), 2018-2033 47

Table 20: Metabolic Disorders Market, China, Average Price ($), 2018-2033 49

Table 21: Metabolic Disorders Market, China, Company Share by Revenue ($m), 2024 51

Table 22: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2018-2033 53

Table 23: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 55

Table 24: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2018-2033 57

Table 25: Metabolic Disorders Market, South Korea, Volume (Units), 2018-2033 59

Table 26: Cholesterol Tests Market, South Korea, Volume (Units), 2018-2033 61

Table 27: Diabetes Assays Market, South Korea, Volume (Units), 2018-2033 64

Table 28: Metabolic Disorders Market, South Korea, Average Price ($), 2018-2033 65

Table 29: Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), 2024 67

Table 30: Metabolic Disorders Market, Australia, Revenue ($m), USD Constant, 2018-2033 69

Table 31: Cholesterol Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 71

Table 32: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2018-2033 73

Table 33: Metabolic Disorders Market, Australia, Volume (Units), 2018-2033 75

Table 34: Cholesterol Tests Market, Australia, Volume (Units), 2018-2033 77

Table 35: Diabetes Assays Market, Australia, Volume (Units), 2018-2033 80

Table 36: Metabolic Disorders Market, Australia, Average Price ($), 2018-2033 81

Table 37: Metabolic Disorders Market, Australia, Company Share by Revenue ($m), 2024 83

Table 38: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2018-2033 85

Table 39: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2018-2033 87

Table 40: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2018-2033 89

Table 41: Metabolic Disorders Market, India, Volume (Units), 2018-2033 91

Table 42: Cholesterol Tests Market, India, Volume (Units), 2018-2033 93

Table 43: Diabetes Assays Market, India, Volume (Units), 2018-2033 96

Table 44: Metabolic Disorders Market, India, Average Price ($), 2018-2033 98

Table 45: Metabolic Disorders Market, India, Company Share by Revenue ($m), 2024 100

Table 46: Metabolic Disorders Market Pipeline Products 103

Table 47: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 110

Figures

Figure 1: Metabolic Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Metabolic Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 12

Figure 3: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 14

Figure 4: Metabolic Disorders Market, Asia-Pacific, Volume (Units), 2018-2033 15

Figure 5: Metabolic Disorders Market, Asia-Pacific, Company Share (%), 2024 17

Figure 6: Metabolic Disorders Market, Japan, Revenue ($m), USD Constant, 2018-2033 19

Figure 7: Cholesterol Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 21

Figure 8: Diabetes Assays Market, Japan, Revenue ($m), USD Constant, 2018-2033 23

Figure 9: Metabolic Disorders Market, Japan, Volume (Units), 2018-2033 25

Figure 10: Cholesterol Tests Market, Japan, Volume (Units), 2018-2033 27

Figure 11: Diabetes Assays Market, Japan, Volume (Units), 2018-2033 30

Figure 12: Metabolic Disorders Market, Japan, Company Share (%), 2024 33

Figure 13: Metabolic Disorders Market, China, Revenue ($m), USD Constant, 2018-2033 35

Figure 14: Cholesterol Tests Market, China, Revenue ($m), USD Constant, 2018-2033 37

Figure 15: Diabetes Assays Market, China, Revenue ($m), USD Constant, 2018-2033 39

Figure 16: Metabolic Disorders Market, China, Volume (Units), 2018-2033 41

Figure 17: Cholesterol Tests Market, China, Volume (Units), 2018-2033 43

Figure 18: Diabetes Assays Market, China, Volume (Units), 2018-2033 46

Figure 19: Metabolic Disorders Market, China, Company Share (%), 2024 50

Figure 20: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2018-2033 52

Figure 21: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 54

Figure 22: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2018-2033 56

Figure 23: Metabolic Disorders Market, South Korea, Volume (Units), 2018-2033 58

Figure 24: Cholesterol Tests Market, South Korea, Volume (Units), 2018-2033 60

Figure 25: Diabetes Assays Market, South Korea, Volume (Units), 2018-2033 63

Figure 26: Metabolic Disorders Market, South Korea, Company Share (%), 2024 66

Figure 27: Metabolic Disorders Market, Australia, Revenue ($m), USD Constant, 2018-2033 68

Figure 28: Cholesterol Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 70

Figure 29: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, 2018-2033 72

Figure 30: Metabolic Disorders Market, Australia, Volume (Units), 2018-2033 74

Figure 31: Cholesterol Tests Market, Australia, Volume (Units), 2018-2033 76

Figure 32: Diabetes Assays Market, Australia, Volume (Units), 2018-2033 79

Figure 33: Metabolic Disorders Market, Australia, Company Share (%), 2024 82

Figure 34: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2018-2033 84

Figure 35: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2018-2033 86

Figure 36: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2018-2033 88

Figure 37: Metabolic Disorders Market, India, Volume (Units), 2018-2033 90

Figure 38: Cholesterol Tests Market, India, Volume (Units), 2018-2033 92

Figure 39: Diabetes Assays Market, India, Volume (Units), 2018-2033 95

Figure 40: Metabolic Disorders Market, India, Company Share (%), 2024 99

Asia-Pacific Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests in real time.

Access a live Asia-Pacific Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Asia-Pacific Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports